C5a Receptor Expression - COVID-19 (C5-COV)

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

March 31, 2020

Primary Completion Date

September 30, 2020

Study Completion Date

August 9, 2023

Conditions
COVID-19
Interventions
OTHER

draw blood

40 mL blood sample will be taken within the first three days of hospitalization, a second sample will be taken between the 5th and 10th day of hospitalization and a third sample will be taken on the 10th day of hospitalization or the day of discharge if earlier.

Trial Locations (1)

13354

Assistance Publique Hôpitaux de Marseille, Marseille

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Innate Pharma

INDUSTRY

lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT04369820 - C5a Receptor Expression - COVID-19 (C5-COV) | Biotech Hunter | Biotech Hunter